Pattara Rattanawong, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brugada Syndrome | 9 | 2024 | 98 | 4.530 |
Why?
|
Death, Sudden, Cardiac | 9 | 2023 | 1568 | 1.640 |
Why?
|
Atrial Fibrillation | 17 | 2024 | 5162 | 1.610 |
Why?
|
Electrocardiography | 15 | 2024 | 6410 | 1.550 |
Why?
|
Cause of Death | 9 | 2019 | 3727 | 0.920 |
Why?
|
Digoxin | 1 | 2024 | 246 | 0.850 |
Why?
|
Catheter Ablation | 8 | 2024 | 2775 | 0.770 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2019 | 125 | 0.700 |
Why?
|
Ventricular Fibrillation | 3 | 2024 | 537 | 0.700 |
Why?
|
Arrhythmias, Cardiac | 4 | 2021 | 2258 | 0.700 |
Why?
|
Aortic Valve | 3 | 2019 | 1968 | 0.690 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2024 | 775 | 0.690 |
Why?
|
Protein-Losing Enteropathies | 1 | 2020 | 45 | 0.680 |
Why?
|
Tachycardia, Ventricular | 6 | 2024 | 1309 | 0.650 |
Why?
|
Pulmonary Veins | 2 | 2022 | 755 | 0.650 |
Why?
|
Tricuspid Valve Stenosis | 1 | 2018 | 26 | 0.630 |
Why?
|
Budesonide | 1 | 2020 | 160 | 0.630 |
Why?
|
Myocardial Reperfusion | 1 | 2019 | 339 | 0.590 |
Why?
|
Atrioventricular Block | 1 | 2018 | 141 | 0.540 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2291 | 0.540 |
Why?
|
Hypotension, Orthostatic | 1 | 2019 | 258 | 0.530 |
Why?
|
Defibrillators, Implantable | 4 | 2022 | 1498 | 0.530 |
Why?
|
Risk Assessment | 22 | 2023 | 24311 | 0.500 |
Why?
|
Tricuspid Valve | 1 | 2018 | 419 | 0.490 |
Why?
|
Aortic Valve Stenosis | 4 | 2019 | 2032 | 0.460 |
Why?
|
Endemic Diseases | 1 | 2015 | 191 | 0.460 |
Why?
|
Heart-Assist Devices | 3 | 2020 | 1292 | 0.440 |
Why?
|
Prosthesis-Related Infections | 1 | 2019 | 491 | 0.440 |
Why?
|
Fontan Procedure | 1 | 2020 | 805 | 0.430 |
Why?
|
Retinal Vessels | 1 | 2019 | 864 | 0.430 |
Why?
|
Pacemaker, Artificial | 1 | 2019 | 828 | 0.420 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2018 | 559 | 0.410 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.390 |
Why?
|
Heart Failure | 7 | 2020 | 11857 | 0.380 |
Why?
|
Bacteremia | 1 | 2018 | 985 | 0.370 |
Why?
|
Risk Factors | 25 | 2023 | 74915 | 0.360 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1033 | 0.360 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2489 | 0.340 |
Why?
|
Family | 1 | 2021 | 3208 | 0.340 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1816 | 0.340 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 2058 | 0.340 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2018 | 1333 | 0.310 |
Why?
|
Retinal Vein Occlusion | 2 | 2019 | 149 | 0.300 |
Why?
|
Patient Readmission | 2 | 2020 | 3308 | 0.300 |
Why?
|
Antiviral Agents | 1 | 2020 | 3063 | 0.290 |
Why?
|
Fever | 1 | 2015 | 1622 | 0.290 |
Why?
|
Coronary Occlusion | 2 | 2019 | 306 | 0.250 |
Why?
|
Humans | 60 | 2024 | 768451 | 0.250 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1359 | 0.250 |
Why?
|
Diagnostic Errors | 1 | 2013 | 1282 | 0.250 |
Why?
|
Anticoagulants | 1 | 2020 | 4840 | 0.230 |
Why?
|
Treatment Outcome | 17 | 2023 | 65409 | 0.230 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Cognition | 1 | 2019 | 7066 | 0.180 |
Why?
|
Cardiotonic Agents | 1 | 2024 | 544 | 0.180 |
Why?
|
Pneumocystis carinii | 1 | 2021 | 72 | 0.180 |
Why?
|
Survival Rate | 6 | 2021 | 12875 | 0.180 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2013 | 2181 | 0.180 |
Why?
|
Survival Analysis | 5 | 2019 | 10125 | 0.170 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2021 | 242 | 0.170 |
Why?
|
Stroke | 3 | 2019 | 9791 | 0.170 |
Why?
|
Myocardial Ischemia | 2 | 2022 | 2139 | 0.170 |
Why?
|
Tuberculosis | 1 | 2013 | 2030 | 0.170 |
Why?
|
Postoperative Complications | 2 | 2020 | 15880 | 0.170 |
Why?
|
Prevalence | 6 | 2019 | 15880 | 0.160 |
Why?
|
Time | 1 | 2021 | 546 | 0.160 |
Why?
|
Atrial Flutter | 1 | 2021 | 253 | 0.160 |
Why?
|
Sepsis | 1 | 2013 | 2602 | 0.160 |
Why?
|
Atrial Premature Complexes | 1 | 2018 | 17 | 0.150 |
Why?
|
Opportunistic Infections | 1 | 2021 | 376 | 0.150 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2018 | 32 | 0.150 |
Why?
|
Methylamines | 1 | 2018 | 136 | 0.150 |
Why?
|
Graves Disease | 1 | 2019 | 239 | 0.150 |
Why?
|
Scrub Typhus | 1 | 2017 | 4 | 0.140 |
Why?
|
Arteriovenous Malformations | 1 | 2020 | 396 | 0.140 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15965 | 0.140 |
Why?
|
China | 1 | 2023 | 2398 | 0.140 |
Why?
|
Comorbidity | 5 | 2019 | 10601 | 0.140 |
Why?
|
Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2016 | 13 | 0.140 |
Why?
|
Neural Tube Defects | 1 | 2019 | 255 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18048 | 0.130 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6551 | 0.130 |
Why?
|
Prognosis | 8 | 2023 | 30028 | 0.130 |
Why?
|
Thailand | 1 | 2017 | 288 | 0.130 |
Why?
|
Cholecystitis, Acute | 1 | 2017 | 76 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2021 | 867 | 0.130 |
Why?
|
Choroid | 1 | 2018 | 363 | 0.130 |
Why?
|
Drug Interactions | 1 | 2020 | 1421 | 0.130 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 159 | 0.120 |
Why?
|
Contrast Media | 2 | 2019 | 5336 | 0.120 |
Why?
|
Male | 24 | 2024 | 364781 | 0.120 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2019 | 362 | 0.120 |
Why?
|
Recurrence | 3 | 2022 | 8510 | 0.120 |
Why?
|
Catheter-Related Infections | 1 | 2018 | 275 | 0.120 |
Why?
|
Female | 24 | 2024 | 396943 | 0.120 |
Why?
|
Doxycycline | 1 | 2017 | 348 | 0.120 |
Why?
|
Coronary Artery Bypass | 2 | 2023 | 2194 | 0.110 |
Why?
|
Mutation | 1 | 2018 | 30243 | 0.110 |
Why?
|
Asia | 1 | 2015 | 627 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1066 | 0.110 |
Why?
|
Pedigree | 1 | 2021 | 4545 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2020 | 1126 | 0.110 |
Why?
|
Treatment Failure | 1 | 2019 | 2656 | 0.100 |
Why?
|
Thromboembolism | 1 | 2019 | 1006 | 0.100 |
Why?
|
Incidence | 3 | 2021 | 21552 | 0.100 |
Why?
|
Middle Aged | 13 | 2024 | 223418 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2017 | 1009 | 0.100 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1414 | 0.100 |
Why?
|
Aged, 80 and over | 6 | 2019 | 59680 | 0.100 |
Why?
|
Albuminuria | 1 | 2015 | 658 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 699 | 0.100 |
Why?
|
Aged | 12 | 2023 | 171520 | 0.100 |
Why?
|
Organ Transplantation | 1 | 2021 | 1177 | 0.090 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1569 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10358 | 0.090 |
Why?
|
Time Factors | 4 | 2021 | 40271 | 0.090 |
Why?
|
Heart Transplantation | 1 | 2024 | 3291 | 0.090 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2016 | 783 | 0.090 |
Why?
|
Endometrium | 1 | 2013 | 407 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 2056 | 0.080 |
Why?
|
Intestines | 1 | 2018 | 1912 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2023 | 81834 | 0.080 |
Why?
|
Myocardial Infarction | 3 | 2019 | 11515 | 0.080 |
Why?
|
Causality | 1 | 2015 | 1255 | 0.080 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 975 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4213 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7246 | 0.070 |
Why?
|
Stroke Volume | 2 | 2020 | 5620 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2019 | 5371 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1299 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2018 | 2102 | 0.070 |
Why?
|
Bacteria | 1 | 2018 | 2226 | 0.070 |
Why?
|
Microscopy | 1 | 2013 | 909 | 0.070 |
Why?
|
Osteoporosis | 1 | 2016 | 1606 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1943 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1320 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2019 | 2195 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2360 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2015 | 1007 | 0.060 |
Why?
|
Critical Illness | 1 | 2018 | 2754 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2018 | 1890 | 0.060 |
Why?
|
Cohort Studies | 2 | 2018 | 41797 | 0.060 |
Why?
|
Adult | 9 | 2024 | 223542 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8081 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2020 | 4713 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7471 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 15638 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10845 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15460 | 0.050 |
Why?
|
Sex Factors | 3 | 2021 | 10647 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3440 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2018 | 22293 | 0.040 |
Why?
|
Sympathectomy | 1 | 2020 | 72 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2021 | 952 | 0.040 |
Why?
|
Fundus Oculi | 1 | 2018 | 560 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 640 | 0.030 |
Why?
|
Young Adult | 3 | 2024 | 60045 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 54914 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2021 | 2863 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26351 | 0.030 |
Why?
|
Chronic Disease | 2 | 2019 | 9382 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1760 | 0.030 |
Why?
|
Mitral Valve | 1 | 2021 | 1473 | 0.030 |
Why?
|
Fluorescein Angiography | 1 | 2018 | 1086 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26395 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2021 | 6242 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12242 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2023 | 4526 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1337 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 30179 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2062 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1465 | 0.020 |
Why?
|
Postoperative Care | 1 | 2015 | 1481 | 0.020 |
Why?
|
Anemia | 1 | 2018 | 1521 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3941 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1876 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2257 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2958 | 0.020 |
Why?
|
Bone Density | 1 | 2016 | 3561 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 13030 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14766 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13655 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9425 | 0.010 |
Why?
|
Depression | 1 | 2020 | 8235 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13497 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18478 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39430 | 0.010 |
Why?
|
Adolescent | 1 | 2015 | 89168 | 0.000 |
Why?
|
Animals | 1 | 2018 | 169418 | 0.000 |
Why?
|